Abionyx Pharma SA
PAR:ABNX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abionyx Pharma SA
PAR:ABNX
|
FR |
|
DZS Inc
NASDAQ:DZSI
|
US |
|
C
|
Caterpillar Inc
PAR:CATR
|
US |
|
Phunware Inc
NASDAQ:PHUN
|
US |
|
Abb Ltd
OTC:ABBNY
|
CH |
Shareholder Yield
Current shareholder yield for ABNX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ABNX Price
Abionyx Pharma SA
| Average Annual Return | 3.27% |
| Standard Deviation of Annual Returns | 49.32% |
| Max Drawdown | -42% |
| Market Capitalization | 100.9m EUR |
| Shares Outstanding | 35 510 000 |
| Percentage of Shares Shorted |
N/A
|
ABNX Return Decomposition
Main factors of price return
Stock Splits
ABNX's latest stock split occurred on May 29, 2026
The company executed a 66-for-65 stock split, meaning that for every 65 shares held, investors received 66 new shares.
Before the split, ABNX traded at 2.915 per share. Afterward, the share price was about 2.86.
The adjusted shares began trading on May 29, 2026. This was the only stock split in ABNX's history.
